Overview
Anu Partanen practices in Kuopio, Finland. Ms. Partanen is rated as an Experienced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Her top areas of expertise are Multiple Myeloma, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, T-Cell Lymphoma, and Bone Marrow Transplant.
Her clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Peripheral T-Cell Lymphoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Bone Marrow TransplantMs. Partanen isAdvanced. Learn about Bone Marrow Transplant.
- Multiple MyelomaMs. Partanen isAdvanced. Learn about Multiple Myeloma.
- Non-Hodgkin LymphomaMs. Partanen isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Partanen isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisMs. Partanen isExperienced. Learn about Agranulocytosis.
- Blood ClotsMs. Partanen isExperienced. Learn about Blood Clots.
- Classical Hodgkin LymphomaMs. Partanen isExperienced. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Ms. Partanen isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Febrile NeutropeniaMs. Partanen isExperienced. Learn about Febrile Neutropenia.